market.doi.bio

The licensed-data
marketplace
for scientific AI.

Scientists sell the rights-clean experimental data locked in their silos — unreleased structures, raw diffraction, negative results — to the AI labs that now need it. Brokered on the doi.bio knowledge graph.

Pre-seed · Raising $250K Steven Ness, PhD  ·  sness@sness.net  ·  market.doi.bio (live)
The Problem

The most valuable science data never leaves the lab.

Released PDB is already free and CC0. The value is in what's not scrapable — and today it's trapped, unlicensable, earning nothing.

"We provide ways for scientists to unlock the value of the data in their silos." — market.doi.bio, founding idea
  • Scientists sit on unreleased structures, raw diffraction, assay panels and negative results — real money, with no way to license or sell it.
  • AI labs need clean, provenance-tracked, indemnified science data to train on — and can't buy it. No marketplace exists.
  • Pharma already trades data in $100M–$1B+ bilateral deals — one-off, lawyer-by-lawyer. No rails, no liquidity, no long tail.
The data exists. The market doesn't.
Why Now

Licensed data just became mandatory.

$1.5B
Bartz v. Anthropic settlement, Sept 2025 — pirated training data is now a balance-sheet liability
EU AI Act
Training-data provenance now required by law — provenance is no longer optional
0
Data marketplaces built for science — a dozen exist, all news / text / media
  • Clean rights are now the only safe input. Labs increasingly need provenance-tracked, indemnified data — and a marketplace that guarantees it is worth more than the raw bytes.
  • Every AI-data marketplace is news & text. TollBit, ProRata, Human Native, Cloudflare — all built tollbooths for media. Science is completely unserved.
Everyone built tollbooths for news.
Nobody built the rails for science.
The Solution

A provenance-first marketplace for science data.

Biochemists and biotech/pharma sell rights-clean data to AI labs — and to each other — with clean licenses, indemnity and gated delivery built in. We hold the metadata and broker the deal; the value flows to the scientist.

01
Browse / search
→
02
Buy & license
→
03
Stripe-Connect split
→
04
Gated, watermarked download
  • Rights-clean by construction — seller attestation, standard license tiers, indemnity, optional verifier badges.
  • Gated & watermarked delivery — AES-256 encrypted at rest, metered downloads, a per-order canary in every file.
  • API-first core — humans, autonomous agents (MCP) and a bulk uploader are all clients of one headless product.
# flagship listing
Helix — Unreleased KRAS G12D
  co-crystal structures
price  $48,000
rights ✓ verified · indemnified
deliver gated · watermarked
For Scientists

Your silo is an asset.

Every biochemist has a hard drive of data that took years and grant money to produce — and currently earns nothing. We turn it into licensable inventory, cleanly and safely.

Structure
Unreleased structures
Embargoed PDB entries and co-crystals — the exact non-scrapable data labs pay most for.
Raw
Diffraction & raw instrument data
Structure factors and raw images — richer than any deposited coordinate file.
Assays
Assay & screening panels
Proprietary compound-target and screening data from lab and ex-pharma vaults.
Negative
Negative & failed results
The experiments nobody publishes — and exactly what models need to learn what doesn't work.
Preprint
Preprints & unpublished notes
Pre-publication findings and lab notes, licensed ahead of the journal.
Vaults
doi.bio knowledge vaults
Curated, annotated markdown vaults — human-scored knowledge, ML-ready.
Unlock the value locked in your data.
The doi.bio Graph

A metadata catalog of all of biochemistry.

market.doi.bio sits on doi.bio — a pre-connected knowledge graph that already maps the entire field: every protein, structure, paper, researcher and company, wired together as plain markdown and summarized for machines.

35M+
Papers (PubMed)
8M+
Full-text articles (PMC)
250M+
Proteins (UniProt)
226K+
Structures (PDB)
67K+
Researcher profiles
104K+
Unified person records
1,000+
Biotech companies
133K+
Indexed graph entities
Not a marketplace with a search box.
A marketplace that already knows the whole field.
The Moat — The Sourcing Engine

Tell us what you need. We know who has it.

When a buyer's request can't be filled from the catalog, the graph ranks who most likely holds the data — on-platform to buy now, or off-platform to warm-recruit. No generalist marketplace can do this. They have no scientific graph.

RFQ "p53-stabilizing co-crystal,
     unpublished"
→ ranked holders Schepartz · Fersht …
→ 0 shared keywords · semantic match
Every unfilled request is a
proprietary demand signal.
PDB structure → UniProt protein290,641
PDB structure → PMID paper204,213
Scholar → publications57,188
Protein → AlphaFold model53,171
One traversable graph — the moat133,626
request → source → new supply → richer catalog
Traction — Built & Live

A working product. Built solo, end-to-end.

Live at market.doi.bio — full stack (API core, web app, agent server) deployed and reboot-safe. Payments run in mock mode pending live Stripe keys and counsel; everything else is real and verified.

Live
Catalog + semantic search
Listings with license tiers and a per-order license snapshot; embedding-based discovery.
Live
Stripe Connect payments
Mock by default; real-mode webhook → fulfilment verified. Platform fee split to sellers & verifiers.
Live
Gated, encrypted, watermarked
AES-256-GCM at rest, metered download, per-order canary in every delivered file.
Live
Seller contribution flow
Create → upload → publish, Connect-gated paid listings, an Open Access free tier.
Live
Semantic sourcing + warm-invite
Graph match → prefilled invite → recruit off-platform holders into the deal.
Live
MCP agent server
Autonomous agents search, post RFQs, and purchase — the market is agent-native.
Agents don't just search the market. They buy.
Business Model

We take a cut of every clean transaction.

Free data (PubMed, PDB, PMC) is the lead-gen funnel. Paid proprietary data is the margin. Biotechs sit on both sides — one population seeds supply and demand, beating the marketplace cold-start.

Free data brings them in.
Proprietary data pays.
Marketplace fee — every sale10–20% / txn
Verification badges — quality + rightsfee / dataset
Sourcing & brokerage — the moatdeal fee
Managed storage & clean-roompremium
Recruiter & broker networkcarved from fee
Market

A market forming right now.

AI training-data market 2033 (projected)$16B+
AI training-data market 2026$3.9B
The science slice our high-value wedgethe wedge

~4× growth in seven years — and the science slice commands the highest price per byte.

Demand is already proven — pharma trades data bilaterally, with no marketplace to sit in between:

Incyte × Genesis Therapeutics>$1B
Illumina — Billion Cell Atlasflagship
Mayo Clinic × Merckmulti-yr
Today: one-off, lawyer-by-lawyer→ us
Why Us

Why this compounds — and can't be cloned.

01 Core
The scientific graph
Anyone can build a checkout. Nobody else has 133K linked entities across all biochemistry — the sourcing engine that fills requests the catalog can't.
02 Timing
Provenance is law now
Bartz + the EU AI Act make rights-clean, indemnified data mandatory — exactly what we broker.
03 Liquidity
Biotechs on both sides
One population buys and sells — the cold-start killer that generalist marketplaces never solve for science.
04 Flywheel
The demand log
Every unfilled RFQ is private signal: request → source → new supply → richer catalog. It compounds.
05 Native
Agent-first architecture
Built API-first with an MCP server. When agents become the buyers, we're already their storefront.
06 Founder
Founder-market fit
Built the graph and the marketplace solo, with CASP-validated scientific judgment. A rare pair.
Founder

The receipts.

Steven Ness — PhD, Computer Science. Solo founder. Built the doi.bio graph and the live market.doi.bio marketplace end-to-end: ingestion, semantic search, payments, gated delivery and the agent server.

Builds the whole stack —
and knows what science is real.
CASP15

Ranked #1 against all 26 competing groups on target T1124 — a blind, refereed, world-level structure-prediction benchmark.

SOLO

Built doi.bio (114K+ files, sub-second search) and the full marketplace stack — server, web app and agent server — alone.

The Ask

Raising $250K pre-seed.

Enough to turn a live product into a business with real deals and clean legal rails.

Solo founder · Steven Ness
1
Legal railsCounsel to make the license pack + indemnity binding, plus storage ToS/DPA — the gate to real paid deals.
2
First dealsRecruit design-partner buyers to post real RFQs; warm-invite the first sellers; close the first biotech → AI-lab transaction.
3
Keep buildingLive Stripe payments, S3 + KMS managed storage, and pgvector for semantic sourcing at scale.
market.doi.bio

Scientists own the data
AI needs. We built
the rails
to sell it.

Provenance-first. Agent-native. Live.
$250K Pre-seed Steven Ness, PhD  ·  sness@sness.net  ·  market.doi.bio
market.doi.bio  /  pre-seed
← → or space to navigate
01 / 14